Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma

Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma

Abstract Background Use of statins is associated with a reduced risk of hepatocellular carcinoma (HCC). However, the effect of statin use on HCC recurrence is unclear. This study aimed to evaluate the effect of statin use on recurrence after curative resection among patients with HCC. Methods We ret...

Full description

Bibliographic Details
Main Authors: Shih-Yu Yang, Chih-Chi Wang, Kuang-Den Chen, Yueh-Wei Liu, Chih-Che Lin, Ching-Hui Chuang, Yu-Chieh Tsai, Chih-Chien Yao, Yi-Hao Yen, Chang-Chun Hsiao, Tsung-Hui Hu, Ming-Chao Tsai
Format: Article
Language:English
Published: BMC 2021-01-01
Series:BMC Cancer
Subjects:
Hepatocellular carcinoma
Statin
Resection
Recurrence
Online Access:https://doi.org/10.1186/s12885-021-07796-7

Internet

https://doi.org/10.1186/s12885-021-07796-7

Similar Items